Myles David C. (CIK 1831216) reported 11 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-01-14). Recent activity: Sell OLMA (10,000 shares), Buy OLMA (50,000 shares), Sell OLMA (49,800 shares), Sell OLMA (200 shares), Buy OLMA (50,000 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-01-14 | Olema Pharmaceuticals, Inc. (OLMA) | CH. DISCOV. & NON-CLIN DEV OFF | Sell | 10,000 | $283,400 |
| 2026-01-14 | Olema Pharmaceuticals, Inc. (OLMA) | CH. DISCOV. & NON-CLIN DEV OFF | Buy | 50,000 | $243,500 |
| 2026-01-14 | Olema Pharmaceuticals, Inc. (OLMA) | CH. DISCOV. & NON-CLIN DEV OFF | Sell | 49,800 | $1.4M |
| 2026-01-14 | Olema Pharmaceuticals, Inc. (OLMA) | CH. DISCOV. & NON-CLIN DEV OFF | Sell | 200 | $5,698 |
| 2026-01-14 | Olema Pharmaceuticals, Inc. (OLMA) | CH. DISCOV. & NON-CLIN DEV OFF | Buy | 50,000 | $243,500 |
| 2026-01-14 | Olema Pharmaceuticals, Inc. (OLMA) | CH. DISCOV. & NON-CLIN DEV OFF | Sell | 14,997 | $428,914 |
| 2026-01-14 | Olema Pharmaceuticals, Inc. (OLMA) | CH. DISCOV. & NON-CLIN DEV OFF | Sell | 35,003 | $1.0M |
| 2025-12-23 | Olema Pharmaceuticals, Inc. (OLMA) | CH. DISCOV. & NON-CLIN DEV OFF | Sell | 1,225 | $34,398 |
| 2025-12-23 | Olema Pharmaceuticals, Inc. (OLMA) | CH. DISCOV. & NON-CLIN DEV OFF | Sell | 43,729 | $1.3M |
| 2025-12-23 | Olema Pharmaceuticals, Inc. (OLMA) | CH. DISCOV. & NON-CLIN DEV OFF | Sell | 6,046 | $189,784 |
| 2025-12-23 | Olema Pharmaceuticals, Inc. (OLMA) | CH. DISCOV. & NON-CLIN DEV OFF | Sell | 9,000 | $0 |
Source: SEC Form 4 filings · as of 2026-01-14